- Clinical Technology
- Adult Immunization
- Hepatology
- Pediatric Immunization
- Screening
- Psychiatry
- Allergy
- Women's Health
- Cardiology
- Pediatrics
- Dermatology
- Endocrinology
- Pain Management
- Gastroenterology
- Infectious Disease
- Obesity Medicine
- Rheumatology
- Nephrology
- Neurology
- Pulmonology
Managing Atopic Dermatitis in Special Populations: Expert Insights for Primary Care
In an interview at AAD 2025, Katrina Abuabara, MD, stressed the importance of collaboration between primary care physicians and dermatologists.
Katrina Abuabara, MD, a researcher and dermatologist at the University of California, San Francisco, spoke with Patient Care Online at the 2025 American Academy of Dermatology Annual Meeting about the biggest takeaways from her presentation on the management of atopic dermatitis (AD) in special populations, including pregnant and lactating women, those with infections, and older adults. Above, Abuabara discusses considerations for determining when to refer patients for systemic therapy versus topical treatments alone and strategies for effective comanagement between primary care physicians and dermatologists. She also provides guidance on navigating treatment options and safety profiles for complex atopic dermatitis patients.
For more 2025 AAD Meeting coverage, please click here.
FDA Approves Guselkumab for Pediatric Plaque Psoriasis and Active Psoriatic Arthritis
September 30th 2025The FDA has approved guselkumab for children aged 6 years and older with moderate to severe plaque psoriasis or active psoriatic arthritis, making it the first IL-23 inhibitor authorized for pediatric use.
Atopic Dermatitis: The Pipeline and Clinical Approaches That Could Transform the Standard of Care
September 24th 2025Patient Care tapped the rich trove of research and expert perspective from the 2025 Revolutionizing Atopic Dermatitis meeting to create a snapshot of the AD care of the future.
